Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma

Anticancer Research

Volumn 26, Issue 1 A, 2006, Pages 311-317

  Teschendorf, Christian ^a,c   Warrington Jr , Kenneth H ^b   Shi, Wenyin ^b   Siemann, Dietmar W ^b   Muzyczka, Nicholas ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Gene therapy; Recombinant AAV2; Recombinant adenovirus; Solid tumor; Transduction efficiency

Indexed keywords

ADENOVIRUS VECTOR; DOUBLE STRANDED DNA; ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; COLONIC NEOPLASMS; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HT29 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, NUDE; PANCREATIC NEOPLASMS; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); TRANSDUCTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 32144446653     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T and He TC: Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1: 149-162, 2001.
2. Ritter T, Lehmann M and Volk H: Improvements in gene therapy: averting the immune response to adenoviral vectors. BioDrugs 16: 3-10, 2002.
3. Snyder RO: Adeno-associated virus-mediated gene delivery. J Gene Med 16: 166-175, 1999.
4. Carter PJ and Samulski RJ: Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6: 17-27, 2000.
5. Maass G, Bogedain C, Scheer U, Michl D, Horer M, Braun-Falco M, Volkenandt M, Schadendorf D, Wendtner CM, Winnacker EL, Kotin RM and Hallek M: Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells. Hum Gene Ther 9: 1049-1059, 1998.
6. Veldwijk MR, Schiedlmeier B, Kleinschmidt JA, Zeller WJ and Fruehauf S: Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks. Eur J Cancer 35: 1136-1142, 1999.
7. Nguyen JT, Wu P, Clouse ME, Hlatky L and Terwilliger EF: Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res 58: 5673-5677, 1998.
8. Kim DW, Harada T, Saito I and Miyamura T: An efficient expression vector for stable expression in human liver cells. Gene 134: 307-308, 1993.
9. Grimm D, Kern A, Rittner K and Kleinschmidt JA: Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 9: 2745-2760, 1998.
10. Zolotukhin S, Byrne B, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski R and Muzyczka N: Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6: 973-985, 1999.
11. Clark KR, Voulgaropoulos F and Johnson PR: A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther 3: 1142-1132, 1996.
12. Hardy S, Kitamura M, Harris-Stansil T, Dai Y and Phipps ML: Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842-1849, 1997.
13. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 14: 365-369, 1967.
14. Gorman CM, Gies D, McCray G and Huang M: The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins: Virology 171: 377-385, 1989.
15. Warrington KJ Jr, Teschendorf C, Cao L, Muzyczka N and Siemann DW: Virally directed enzyme/prodrug therapy using adeno-associated viral vectors: DT-diaphorase and bioreductive agents. Int J Rad Oncol Biol Phys 42: 909-912, 1998.
16. Vermeij J, Zeinoun Z, Neyns B, Teugels E, Bourgain C and De Gerve J: Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector. Br J Cancer 85: 1592-1599, 2001.
17. Peng D, Qian C, Sun Y, Barajas MA and Prieto J: Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol 32: 975-985, 2000.
18. Snyder RO, Miao CH, Patjin GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR and Kay MA: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Gen 16: 270-276, 1997.
19. Duan D, Sharma P, Yang J, Yue Y, Dudus L, Zhang Y, Fisher KJ and Englehardt JF: Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72: 8568-8577, 1998.
20. Ferrari F, Samulski T, Shenk T and Samulski RJ: Second strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated viral vectors. J Virol 70: 3227-3234, 1996.
21. Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S and Srivastava A: Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 75: 8968-8976, 2001.
22. Halbert CL, Alexander IE, Wolgamot GM and Miller AD: Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 69: 1473-1479, 1995.
23. Russell DW, Alexander IE and Miller AD: DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 92: 5719-5723, 1995.
24. Kovesdi I, Brough DE, Bruder JT and Wickham TJ: Adenoviral vectors for gene transfer. Curr Opin Biotechnol 8: 583-589, 1997.
25. Summerford C and Samulski RJ: Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72: 1438-1445, 1998.
26. Teschendorf C, Warrington KH Jr, Siemann DW and Muzyczka N: Comparison of the EF-1α and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Res 22: 3325-3330, 2002.
27. Shi W, Teschendorf C, Muzyczka N and Siemann DW: Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo. Cancer Gene Ther 9: 513-521, 2002.
28. Davidoff AM, Nathwani AC, Spurbeck WW, Ng CY, Zhou J and Vanin EF: RAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res 62: 3077-3083, 2002